You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | -200.6% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.8 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 4.0 | n/a |
| Price / Book value | 1.9 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 90.3% | n/a |
| PBT | 0.0% | n/a |
| EPS | 0.0% | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 1.70 | -3.51 | -17.00p | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | 1.16 | -6.95 | -27.00p | -14.8 | 0.0 | n/a | n/a | 0.0% |
| 2022-12-31 | 2.40 | -10.54 | -32.00p | -7.5 | 0.0 | n/a | n/a | 0.0% |
| 2023-12-31 | 4.57 | -8.90 | -28.00p | -6.5 | 0.0 | n/a | n/a | 0.0% |
| Revenue higher, cash reserves fall at Arecor Sharecast News | 03 Feb |
|---|---|
| Arecor to wind up operations at Tetris Pharma subsidiary Sharecast News | 10 Jan |
| Arecor upbeat on signing of exclusive licensing deal Sharecast News | 30 Dec |
| Arecor partnership with biopharmaceutical company | 12-Mar-25 07:01 |
|---|---|
| Arecor Full Year 2024 Trading Update | 03-Feb-25 07:01 |
| Orderly Cessation of Tetris Pharma Operations | 10-Jan-25 07:45 |
| Change of Nominated Advisor and Joint Broker | 09-Jan-25 07:01 |
| Arecor Signs Exclusive Licensing Agreement | 30-Dec-24 07:01 |